Construction and validation of a prognostic model for osteosarcoma patients based on autophagy-related genes Biao NingYixin LiuYongchang Wei Research Open access 31 December 2022 Article: 146
Integrated radiomics, dose-volume histogram criteria and clinical features for early prediction of saliva amount reduction after radiotherapy in nasopharyngeal cancer patients Lang ZhouWanjia ZhengXin Yang Research Open access 30 December 2022 Article: 145
Can patients with good tumor regression grading after neoadjuvant chemoradiotherapy be exempted from lateral lymph node dissection? Xianwei LiuXuyang YangZiqiang Wang Research Open access 30 December 2022 Article: 144
Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification Vitória Brum da Silva NunesCamila Kehl DiasFabrício Figueiró Research Open access 30 December 2022 Article: 143
Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs Laxmi ManthalkarAjazuddinSankha Bhattacharya Review Open access 26 December 2022 Article: 142
Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer Young Sol HwangHwa Jung KimSae Byul Lee Research Open access 23 December 2022 Article: 141
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy Manuel NeubergerChristel WeißPhilipp Nuhn Research Open access 15 December 2022 Article: 140
Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis Longji WuJing HuangXiangning Zhang Review Open access 15 December 2022 Article: 139
Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1 Jianjun LiYaqi KouShuang Yang Research Open access 13 December 2022 Article: 138
Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathway Rui ZhangTianjiao HuangXuemei Wang Research Open access 11 December 2022 Article: 137
USF1-CHCHD4 axis promotes lung adenocarcinoma progression partially via activating the MYC pathway Yuhui ZhouYunxia ZhaoWei Dong Research Open access 08 December 2022 Article: 136
Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells Diandra Zipinotti dos SantosIsabella dos Santos GuimaraesLeticia B. A. Rangel Research Open access 08 December 2022 Article: 135
SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma Huayi FengTao WangXu Zhang Research Open access 07 December 2022 Article: 134
Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer Jia ChenYu GuanChaozhao Liang Research Open access 01 December 2022 Article: 133
PAIP1 is a novel oncogene in human hepatocellular carcinoma Nuobei ZhangXin Chen Research Open access 27 November 2022 Article: 132
Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma Fanhua KongKunpeng WangLiezhi Wang Research Open access 25 November 2022 Article: 131
High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: an endemic area population-based study Chia-Chin LiChih-Yi ChenChun-Ru Chien Research Open access 24 November 2022 Article: 130
Local control comparison of early-stage non-melanoma skin Cancer (NMSC) treated by superficial radiotherapy (SRT) and external beam radiotherapy (XRT) with and without dermal image guidance: a meta-analysis Lio YuMairead MoloneyJames Rogers Research Open access 21 November 2022 Article: 129
Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma Tian-Yan DingYu-Hui PengFang-Cai Wu Research Open access 21 November 2022 Article: 128
Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer Yanhui WanYouhui QianGuodong Wu Research Open access 19 November 2022 Article: 127
Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas Eric J. HsuJamie ThomasDat T. Vo Research Open access 15 November 2022 Article: 126
Development and validation of a ferroptosis-related lncRNAs signature to predict prognosis and microenvironment for melanoma Shuai PingRuining GongJianghai Chen Research Open access 12 November 2022 Article: 125
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma Domenica RonchettiVanessa Katia FavasuliAntonino Neri Brief Communication Open access 11 November 2022 Article: 124
The diagnostic accuracy of intraoperative differentiation and delineation techniques in brain tumours Laura Van HeseSteven De VleeschouwerEva Cuypers Review Open access 10 November 2022 Article: 123
Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma Hairuo WenXiaoyan LouYing Huang Research Open access 09 November 2022 Article: 122
Kruppel-like factor 13 inhibits cell proliferation of gastric cancer by inducing autophagic degradation of β-catenin Youxiang DingYuting XuXiangshan Fan Research Open access 06 November 2022 Article: 121
Crosstalk between ROCK1 and PYROXD1 regulates CAFs activation and promotes laryngeal squamous cell carcinoma metastasis Liyun YangPeipei QiaoShuixian Huang Research Open access 05 November 2022 Article: 120
New thiophene derivative augments the antitumor activity of γ-irradiation against colorectal cancer in mice via anti-inflammatory and pro-apoptotic pathways Nermeen M. ElBakarySanaa A. HagagWael M. El-Sayed Research Open access 03 November 2022 Article: 119
Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy Miaomiao GouYong Zhang Research Open access 03 November 2022 Article: 118
BAP1 in cancer: epigenetic stability and genome integrity Sabrina CaporaliAlessio ButeraIvano Amelio Perspective Open access 01 November 2022 Article: 117
The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989 Gustav StålhammarPete A. WilliamsTomas Landelius Research Open access 31 October 2022 Article: 116
Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review Ting-Yu LinYen-Fu ChenLevent Özçakar Review Open access 28 October 2022 Article: 115
LINC01089 blocks malignant progression of thyroid cancer by binding miR-27b-3p to enhance the FBLN5 protein level Yong-qin PanKun-song HuangJin-yi Li Research Open access 28 October 2022 Article: 114
Natural killer cell immunotherapy in glioblastoma Hamed HosseinalizadehMehryar Habibi RoudkenarTomoaki Sato Review Open access 28 October 2022 Article: 113
Application of radiomics in adrenal incidentaloma: a literature review Cheng LiYan FuBihong T. Chen Review Open access 28 October 2022 Article: 112
Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision Fang HeMo ChenJian Zheng Research Open access 21 October 2022 Article: 111
The relationship of serum gastrin-17 and oral mucositis in head and neck carcinoma patients receiving radiotherapy Congye WuYehong LiuHuanyu Zhao Research Open access 21 October 2022 Article: 110
Evaluation of an inflammation-based score for identification of appropriate patients for comprehensive genomic profiling Naomi HayashiIppei FukadaShunji Takahashi Research Open access 19 October 2022 Article: 109
Prostate cancer induced bone pain: pathobiology, current treatments and pain responses from recent clinical trials A. E. SmithA. MuralidharanM. T. Smith Review Open access 18 October 2022 Article: 108
Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6 Razan ZatarahNour FaqeerLama Nazer Research Open access 17 October 2022 Article: 107
High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients Justyna DurślewiczJakub JóźwickiMarcin Braun Research Open access 15 October 2022 Article: 106
Tumor Treating Fields (TTFields) therapy vs physicians’ choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19) Jay-Jiguang ZhuSamuel A. GoldlustZvi Ram Research Open access 14 October 2022 Article: 105
Giant adrenal ganglioneuroma in children: a case report Mingqiu HuZhizhong TangXiaolu Yuan Case Report Open access 14 October 2022 Article: 104
Combination bromo- and extraterminal domain and poly (ADP-ribose) polymerase inhibition synergistically enhances DNA damage and inhibits neuroblastoma tumorigenesis Jillian C. JacobsonJingbo QiaoDai H. Chung Research Open access 13 October 2022 Article: 103
Silencing of long non-coding RNA TUC338 inhibits the malignant phenotype of nasopharyngeal cancer cells via modulating the miR-1226-3p/FGF2 axis Jian WangLiping LiYing Zhang Research Open access 12 October 2022 Article: 102
Knockdown of RAD51AP1 suppressed cell proliferation and invasion in esophageal squamous cell carcinoma Yang-Yang HuChen-Chao MaKai-Xing Ai Research Open access 05 October 2022 Article: 101
Rho-associated kinase1 promotes laryngeal squamous cell carcinoma tumorigenesis and progression via the FAK signaling pathway Liyun YangPeipei QiaoAn Hu Research Open access 05 October 2022 Article: 100
A Novel CTLA-4 affinity peptide for cancer immunotherapy by increasing the integrin αvβ3 targeting Ying ZhouShuyi SongGuodong Li Research Open access 04 October 2022 Article: 99
Fucoxanthin induces apoptosis and reverses epithelial-mesenchymal transition via inhibiting Wnt/β-catenin pathway in lung adenocarcinoma Heqi LuanLina YanLihua Cao Research Open access 03 October 2022 Article: 98
Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A Nichelle C. WhitlockMargaret E. WhiteAdam G. Sowalsky Research Open access 01 October 2022 Article: 97
